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Mutations in a Keratin 6 Isomer (K6c) 
Cause a Type of Focal  
Palmoplantar Keratoderma
Paul E. Bowden1
Twenty years have elapsed since keratin mutations were linked to cutaneous 
genodermatoses, and we now know that they cause 40 different genetic dis-
orders. In this issue, Wilson et al. have identified KRT6C mutations in patients 
with focal palmoplantar keratoderma (FPPK), but debate concerning overlap-
ping phenotypes between FPPK and pachyonychia congenita (PC) will con-
tinue because only one family has nail involvement. Furthermore, screening of 
control DNA samples identified 3 in 335 individuals (1%) who had a mutation 
(K6c p.Asn172del), but the phenotype was not ascertained. However, this raises 
the question as to whether individuals with sensitive feet bear specific KRT6C 
mutations and whether a general population screen should be considered. 
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Keratin genodermatoses:  
20 years down the road
It has been two decades since it was 
established that truncation of small 
specific regions of a keratin protein 
would severely affect the ability of 
keratin filaments to function normal-
ly. Although this affected only one of 
four genetic alleles involved in basic 
filament assembly and only 25% of 
the total protein content of the fila-
ment bore the small alteration, it was 
sufficient to cause filament collapse 
in cultured keratinocytes (Albers and 
Fuchs, 1987). A few years later, experi-
ments with transgenic mice provided 
the first definitive link between keratin 
structural alterations and cutaneous 
genodermatoses (Vassar et al., 1991). 
Single point mutations in specific 
keratin genes were then found to be 
causal in patients with two hereditary 
skin diseases: epidermolysis bullosa 
simplex, caused by mutations in K5 
or K14 (Coulombe et al., 1991), and 
epidermolytic hyperkeratosis, caused 
by mutations in K1 or K10 (Rothnagel 
et al., 1992). Thus, single heterozygous 
point mutations in one allele were 
sufficient to exert a dominant nega-
tive effect over the normal allele in the 
majority of cases, providing an expla-
nation for the autosomal dominant 
nature of most keratin-based geno-
dermatoses (Irvine and McLean, 1999).
Further research established the 
existence of more than 350 unique 
keratin mutations in 21 keratin genes 
that were the cause of 40 genoder-
matoses. Many keratin mutations 
were unique, but trends appeared 
that established hot spots for muta-
tion in the genes that coincided with 
sensitive regions of the protein struc-
ture. Thus, alterations in the proximal 
1A helical amino acid residues (helix 
initiation peptide) and the distal 2B 
helical residues (helix termination 
peptide) accounted for the majority 
(75%) of the known mutations. Within 
these regions, however, the sensitivity 
of specific amino acid residues var-
ied, and mutation of adjacent residues 
could lead to significant differences in 
disease severity (Liovic et al., 2004). 
In addition, evidence from family 
studies indicated that identical muta-
tions could have different phenotypic 
presentations in members of the same 
family, arguing for modulation of the 
phenotype by an individual’s genetic 
background.
How many keratin genes?
It is well established that keratin inter-
mediate filament proteins are essential 
components of the cytoskeleton of all 
mammalian epithelial cells. They form 
two large multigene families at sepa-
rate chromosomal loci, with all type II 
keratin genes and a single type I gene 
(encoding K18) located at 12q11–q13 
and the remaining type I keratin genes 
at 17q11–q21. Keratins are obligate 
heteropolymers, with filament assem-
bly requiring a combination of type I 
and type II proteins. They were origi-
nally defined by their biochemical 
properties (Moll et al., 1982; Bowden 
et al., 1987)—the 11 type I keratins 
(K9–K19) were smaller (40–65 kDa) 
and more acidic (pI 4.5–6.0) than the 
8 (K1–K8) type II keratins (50–70 kDa, 
pI 6.5–8.5). Recent bioinformatics 
based on the human genome project 
sequences has established that there 
are 54 functional keratin genes (abbre-
viated KRT): 31 epithelial keratins, 15 
hair-specific keratins, and 8 inner root 
sheath keratins (Hesse et al., 2004). 
Furthermore, a unified nomenclature 
was recently established for all known 
keratin intermediate filament genes 
and proteins (Schweizer et al., 2006). 
This leaves 33 keratin genes in which 
mutations have not yet been identified 
and that are not yet associated with 
any genetic disorder.
complications surrounding  
keratin 6 (K6)
Initially, two K6 proteins were iden-
tified (K6a and K6b), but evidence 
was presented for six isoforms of K6 
(Takahashi et al., 1995), each encod-
ed by a separate gene (KRT6a–6f). 
This was followed by the discovery of 
another K6-sized protein in the com-
panion layer (K6hf) and several spe-
cific keratins in the inner root sheath, 
termed K6irs. It was known from 
genodermatoses studies that muta-
tions in K6a and K6b caused different 
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phenotypic forms of pachyonychia 
congenita (PC) and that these were 
the probable partners of K16 and 
K17, respectively, but no evidence 
from genetic studies supported the 
existence of other K6 isoforms. The 
original six proposed isoforms were 
eventually reduced to three (K6a, 
K6b, and K6c) encoded by three func-
tional isogenes (KRT6A, KRT6B, and 
KRT6C), based on sequence informa-
tion from the human genome project 
and studies of the chromosomal locus 
(Rogers et al., 2005). Furthermore, to 
avoid confusion, the other K6 pro-
teins of the hair follicle were renamed 
(Schweizer et al., 2006).
mutations in KRT6C:  
another keratin gene nailed
In this issue, Wilson et al. implicate 
mutations in the third functional K6 
gene (KRT6C) as causal in focal pal-
moplantar keratoderma (FPPK). These 
investigators have examined three 
FPPK families (two four-generation 
families and a two-generation family) 
and found a remarkably consistent 
phenotype with mainly plantar hyper-
keratosis and blistering. There appears 
to be little if any palm involvement, 
but some minor nail changes were 
found in one family, suggesting a pos-
sible phenotypic overlap with PC. This 
nail disease has two major phenotypic 
variants: PC-1 is caused by muta-
tions in KRT6A or KRT16 (Bowden 
et al., 1995; McLean et al., 1995), 
whereas PC-2 is caused by mutations 
in KRT6B or KRT17 (PC-2: McLean et 
al., 1995; Smith et al., 1998). Patients 
with focal nonepidermolytic palmo-
plantar keratoderma (PPK; FNEPPK: 
OMIM #613000) have been found to 
bear mutations in KRT16 (Smith et al., 
2000), again representing a pheno-
typic overlap with PC-1. The FPPK 
phenotype also resembles another 
palmoplantar disorder, hereditary 
painful callosities (HPC: OMIM 
%114140), in which some patients 
have lesions on the palms and others 
do not (Roth et al., 1978; Baden et 
al., 1984). Close examination of the 
clinical photographs in this issue and 
those previously published for HPC 
reveals a close similarity. In addition, 
preliminary data from two other HPC 
families with an identical phenotypic 
presentation confirm the ability of 
KRT6C mutations to cause pathology 
(Easter et al., 2009.).
Palmoplantar keratoderma:  
a phenotypic mixed bag
Palmoplantar epidermis not only is 
thicker than the epidermis at other 
anatomical sites but also has a more 
complex pattern of keratin expres-
sion; it is an adaptive tissue capable of 
resisting mechanical trauma (Bowden 
et al., 1987; Swensson et al., 1998). 
Pathology of the skin at this loca-
tion produces excessive thickening, 
blistering, and cell fragility, typical 
manifestations of a large group of 
geno dermatoses collectively known 
as PPKs. The hyperkeratotic pheno-
type can be focal, striate, diffuse, or 
punctuate, and this can be the only 
pathology in a given family or part of a 
complex syndrome. The genetic cause 
has been elucidated for several of the 
PPKs; not only keratin gene mutations 
but also a wide range of other genes 
may be involved. Many of the pheno-
typic differences are minor or subtle, 
and isolating them into a group with 
a single genetic cause can be difficult. 
However, in the case of K6c muta-
tions, the phenotype appears to be 
quite distinct. Perhaps more of these 
cases will come to light over the next 
few years, allowing a larger number of 
K6c mutations to be identified.
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localization for CTGF, TGF-β, and 
type I procollagen-α1, as well as 
CTGF’s effects on TGF-β signaling. 
Using samples of young (21–30 years 
of age) and aged (80 or more years 
of age) but otherwise normal human 
skin, and laser-capture microdissect-
ed cells, the authors show that TGF-β 
and CTGF are normally expressed and 
produced in skin and skin fibroblasts. 
Comparing samples from young and 
aged subjects, Quan et al. found that 
in aged skin and fibroblasts, TGF-β, 
CTGF, and type I procollagen mRNA 
and protein levels were coordinately 
reduced. Using transfected normal 
human dermal fibroblasts, knock-
down of CTGF was associated with 
decreased type I procollagen promoter 
activity (COL1A2), mRNA, and pro-
tein content, whereas overexpression 
of V5-tagged human CTGF increased 
the same readouts. Three approaches 
to block signaling due to endogenous 
TGF-β were used to assess molecular 
mechanisms by which CTGF modu-
lates type I procollagen: (i) a specific 
TGF-βRI kinase inhibitor SB431542, 
(ii) Smad4 knockdown, and (iii) over-
expression of inhibitory Smad7. All 
approaches completely blocked the 
CTGF-mediated increase in type I pro-
collagen expression and production, 
indicating that TGF-β receptor and 
Smad signaling are required. However, 
no effects of CTGF knockdown or over-
expression were observed on TGF-β-
dependent Smad2/3 phosphorylation 
or Smad3 transcriptional activity.
On the basis of these findings, the 
authors conclude that endogenous 
production of both TGF-β and CTGF 
in human dermal fibroblasts normally 
acts to modulate type I procollagen 
expression in skin. They propose that 
this involves a TGF-β/Smad/CTGF 
axis that is operated by interdepen-
dent, yet distinct, mechanisms to 
regulate type I procollagen produc-
tion. Decreased expression of TGF-β 
and CTGF by aged skin fibroblasts is 
proposed to underlie age-associated 
downregulation of the TGF-β/Smad/
CTGF axis, thereby leading to reduced 
type I procollagen expression. These 
results suggest beneficial effects of 
CTGF and provide novel insight into 
the mechanisms of skin aging.
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Could Aging Human skin Use a 
Connective Tissue Growth Factor 
Boost to Increase Collagen Content?
Noelynn Oliver1, Mark Sternlicht1, Karin Gerritsen2  
and Roel Goldschmeding1,2
The roles of connective tissue growth factor (CTGF) and transforming growth 
factor-β (TGF-β), both well-known collagen production stimulators, were 
examined in skin aging. Aged skin and fibroblasts exhibited a coordinate 
decrease in CTGF, TGF-β, and type I procollagen expression and content. CTGF 
knockdown and TGF-β blockade in normal dermal fibroblasts reduced procol-
lagen expression, whereas overexpressing CTGF increased procollagen by a 
TGF-β/smad signaling–dependent mechanism without involving smad2/3.
Journal of Investigative Dermatology (2010) 130, 338–341. doi:10.1038/jid.2009.331
Background
Type I collagen is a major struc-
tural protein in human skin and, by 
mass, the most abundant protein in 
the human body. The association of 
age-dependent collagen loss with 
thinning and fragility of elderly skin 
has long been appreciated, yet the 
underlying mechanisms are not well 
understood. A recent study (Quan 
et al., 2010, this issue) suggests that 
diminished expression of connective 
tissue growth factor (CTGF), together 
with diminished transforming growth 
factor (TGF)-β/Smad signaling, is 
responsible for this progressive loss of 
dermal collagen. CTGF is a secreted, 
matri cellular protein, and, like that 
of other such proteins, its function is 
thought to be regulatory, not struc-
tural. CTGF is generally considered a 
pathogenic factor because of its many 
reported disease associations (Leask 
et al., 2009; Cicha et al., 2009), 
potential macromolecular interac-
tions, and complex gene regulation 
that also involves disease-associated 
processes and factors (Figure 1). The 
evolution of a purely pathogenic fac-
tor is unlikely without invoking an 
extreme selfish-gene concept, and the 
results of Quan et al., which address 
CTGF function in normal young and 
aging skin, provide an alternative 
view of CTGF’s physiological signifi-
cance in tissue homeostasis.
ctGF in aging skin: new findings
By means of associative and mecha-
nistic in vivo and in vitro studies, 
Quan et al. (2010) probe the impor-
tance of CTGF and TGF-β for col-
lagen loss in aging skin. They report 
findings on expression, content, and 
